BlackRock, Inc. 13D and 13G filings for LENZ Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 6:13 pm Purchase | 2025-09-30 | 13G | LENZ Therapeutics, Inc. LENZ | BlackRock Inc. BLK | 1,442,864 5.100% | 1,442,864 (New Position) | Filing |